EIF2A and familial pancreatic carcinoma: Gene enrichment analysis showed that by blocking eIF2a phosphorylation and reducing ATF4 translation, acriflavine inhibited the unfolded protein-responsive PERK/eIF2a/ATF4 pathway, that is, acriflavine restored the drug sensitivity of acquired drug-resistant pancreatic cancer cell lines.